UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000060414
Receipt number R000068015
Scientific Title Impact of large-volume ascites on the outcomes of ERCP and EUS-guided biliary drainage in malignant biliary obstruction
Date of disclosure of the study information 2026/10/20
Last modified on 2026/01/20 17:59:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Impact of large-volume ascites on the outcomes of ERCP and EUS-guided biliary drainage in malignant biliary obstruction

Acronym

Impact of large-volume ascites on the outcomes of ERCP and EUS-guided biliary drainage in malignant biliary obstruction

Scientific Title

Impact of large-volume ascites on the outcomes of ERCP and EUS-guided biliary drainage in malignant biliary obstruction

Scientific Title:Acronym

Impact of large-volume ascites on the outcomes of ERCP and EUS-guided biliary drainage in malignant biliary obstruction

Region

Japan


Condition

Condition

Malignant biliary obstruction

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The primary outcome is the safety of ERCP and EUS-BD.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Primary outcome is the safety of biliary drainage, as assessed by the incidence, type, timing, and severity of AEs.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

malignant distal biliary obstruction
large-volume ascites

Key exclusion criteria

<20 years old

Target sample size

156


Research contact person

Name of lead principal investigator

1st name Yusuke
Middle name
Last name Ishida

Organization

Department of Gastroenterology and Medicine, Faculty of Medicine, Fukuoka University, Fukuoka, Japan

Division name

Department of Gastroenterology and Medicine, Faculty of Medicine, Fukuoka University, Fukuoka, Japan

Zip code

814-0180

Address

7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan

TEL

0928639759

Email

takehikoga@gmail.com


Public contact

Name of contact person

1st name Takehiko
Middle name
Last name Koga

Organization

Department of Gastroenterology and Medicine, Faculty of Medicine, Fukuoka University, Fukuoka, Japan

Division name

Department of Gastroenterology and Medicine, Faculty of Medicine, Fukuoka University, Fukuoka, Japan

Zip code

814-0180

Address

7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan

TEL

09083917399

Homepage URL


Email

takehikoga@gmail.com


Sponsor or person

Institute

Fukuoka University

Institute

Department

Personal name



Funding Source

Organization

Fukuoka University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB of Fukuoka University

Address

7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan

Tel

0928011011

Email

fu-merb-bigvan@fukuoka-u.ac.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

H25-04-005

Org. issuing International ID_1

IRB of Fukuoka University

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 10 Month 20 Day


Related information

URL releasing protocol

n/a

Publication of results

Partially published


Result

URL related to results and publications

n/a

Number of participants that the trial has enrolled

156

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2025 Year 04 Month 07 Day

Date of IRB

2025 Year 04 Month 07 Day

Anticipated trial start date

2025 Year 04 Month 07 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

na


Management information

Registered date

2026 Year 01 Month 20 Day

Last modified on

2026 Year 01 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068015